Suppr超能文献

全身性施瓦茨曼反应期间的肺部效应以及地塞米松或维生素E的治疗干预。

Lung effects during a generalized Shwartzman reaction and therapeutic intervention with dexamethasone or vitamin E.

作者信息

Rocksén David, Koch Bo, Sandström Thomas, Bucht Anders

机构信息

Department of Medical Countermeasures, Divison of NBC Defence, Swedish Defence Research Agency, Umeå, Sweden.

出版信息

Shock. 2004 Nov;22(5):482-90. doi: 10.1097/01.shk.0000142254.38630.36.

Abstract

We investigated if a two-hit shock model, commonly referred to as generalized Shwartzman reaction (GSR), can prime for indirect acute respiratory distress syndrome (ARDS) in mice. The GSR was provoked in C57BL/6 mice by two consecutive i.p. injections of 100 microg lipopolysaccharide (LPS) at t = 0 and t = 20 h. These mice demonstrated a dramatic decrease in respiratory capacity and 80% mortality after the second injection. No such effect was observed when LPS was given as a single 200 microg dose at t = 0. Increased expression of proinflammatory cytokines in serum (interleukin-1beta, interleukin-6 and interferon-gamma), lung neutrophilia, and edema formation were observed in mice injected with one dose of LPS, but notably, mice exposed twice did not further increase their inflammatory response. Early treatment 1 h after the first LPS injection (t = 1 h) with either dexamethasone (10 mg/kg) or vitamin E (50 mg/kg) improved respiratory function and down-modulated the induction of proinflammatory cytokines in serum. In conclusion, mice with a generalized Shwartzman reaction exhibited features resembling some aspects of the pathophysiology in septic ARDS, i.e., neutrophilic inflammation, edema formation, impaired respiratory capacity, and mortality. Our data indicate that a systemic cytokine response and lung neutrophilia may prime for the GSR but that other mechanisms account for the rapid decline in lung function after the second challenge. We suggest that this model can be used for studies of pathogenesis and therapeutic prevention of acute respiratory failure.

摘要

我们研究了一种通常被称为广义施瓦茨曼反应(GSR)的两次打击休克模型是否能引发小鼠间接急性呼吸窘迫综合征(ARDS)。在C57BL/6小鼠中,于t = 0小时和t = 20小时通过腹腔内连续两次注射100微克脂多糖(LPS)来激发GSR。这些小鼠在第二次注射后呼吸能力显著下降,死亡率达80%。当在t = 0小时给予单次200微克剂量的LPS时,未观察到这种效应。在注射一剂LPS的小鼠中观察到血清中促炎细胞因子(白细胞介素-1β、白细胞介素-6和干扰素-γ)表达增加、肺中性粒细胞增多以及水肿形成,但值得注意的是,接受两次注射的小鼠并未进一步增强其炎症反应。在首次注射LPS后1小时(t = 1小时)早期给予地塞米松(10毫克/千克)或维生素E(50毫克/千克)可改善呼吸功能,并下调血清中促炎细胞因子的诱导。总之,具有广义施瓦茨曼反应的小鼠表现出类似于脓毒症性ARDS病理生理学某些方面的特征,即中性粒细胞炎症、水肿形成、呼吸能力受损和死亡率。我们的数据表明,全身性细胞因子反应和肺中性粒细胞增多可能引发GSR,但其他机制导致了第二次攻击后肺功能的快速下降。我们建议该模型可用于急性呼吸衰竭发病机制和治疗性预防的研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验